These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 30815953)
1. Experience of the implementation and outcomes of universal testing for Lynch syndrome in the United Kingdom. Cavazza A; Radia C; Harlow C; Monahan KJ Colorectal Dis; 2019 Jul; 21(7):760-766. PubMed ID: 30815953 [TBL] [Abstract][Full Text] [Related]
2. Lynch syndrome screening in colorectal cancer: results of a prospective 2-year regional programme validating the NICE diagnostics guidance pathway throughout a 5.2-million population. West NP; Gallop N; Kaye D; Glover A; Young C; Hutchins GGA; Brockmoeller SF; Westwood AC; Rossington H; Quirke P; Histopathology; 2021 Nov; 79(5):690-699. PubMed ID: 33872400 [TBL] [Abstract][Full Text] [Related]
3. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer. Hampel H; Pearlman R; Beightol M; Zhao W; Jones D; Frankel WL; Goodfellow PJ; Yilmaz A; Miller K; Bacher J; Jacobson A; Paskett E; Shields PG; Goldberg RM; de la Chapelle A; Shirts BH; Pritchard CC; JAMA Oncol; 2018 Jun; 4(6):806-813. PubMed ID: 29596542 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome. Vos JR; Fakkert IE; Spruijt L; Willems RW; Langenveld S; Mensenkamp AR; Leter EM; Nagtegaal ID; Ligtenberg MJL; Hoogerbrugge N; Int J Cancer; 2020 Oct; 147(8):2150-2158. PubMed ID: 32510614 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study. Li D; Hoodfar E; Jiang SF; Udaltsova N; Pham NP; Jodesty Y; Armstrong MA; Hung YY; Baker RJ; Postlethwaite D; Ladabaum U; Levin TR; Corley DA; Bergoffen J Ann Intern Med; 2019 Jul; 171(1):19-26. PubMed ID: 31181578 [TBL] [Abstract][Full Text] [Related]
7. Consequences of testing for mismatch repair deficiency of colorectal cancer in clinical practice. Leicher LW; Lammertink MHA; Offerman SR; Morreau H; de Jong MM; de Groot JWB; van Westreenen HL; Vasen HFA; de Vos Tot Nederveen Cappel WH Scand J Gastroenterol; 2018 May; 53(5):632-636. PubMed ID: 29161904 [TBL] [Abstract][Full Text] [Related]
8. Impact of universal immunohistochemistry on Lynch syndrome diagnosis in an Australian colorectal cancer cohort. Loh Z; Williams DS; Salmon L; Dow E; John T Intern Med J; 2019 Oct; 49(10):1278-1284. PubMed ID: 30667141 [TBL] [Abstract][Full Text] [Related]
9. Identification of Lynch syndrome among patients with colorectal cancer. Moreira L; Balaguer F; Lindor N; de la Chapelle A; Hampel H; Aaltonen LA; Hopper JL; Le Marchand L; Gallinger S; Newcomb PA; Haile R; Thibodeau SN; Gunawardena S; Jenkins MA; Buchanan DD; Potter JD; Baron JA; Ahnen DJ; Moreno V; Andreu M; Ponz de Leon M; Rustgi AK; Castells A; JAMA; 2012 Oct; 308(15):1555-65. PubMed ID: 23073952 [TBL] [Abstract][Full Text] [Related]
10. A dedicated high-quality service for the management of patients with an inherited risk of colorectal cancer. Adams LK; Qiu S; Hunt AK; Monahan KJ Colorectal Dis; 2019 Aug; 21(8):879-885. PubMed ID: 30903731 [TBL] [Abstract][Full Text] [Related]
11. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation. Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526 [TBL] [Abstract][Full Text] [Related]
12. Compliance with mismatch repair testing in pT1 colorectal cancer diagnosed before the age of 70 years. Ykema BLM; Nagtegaal ID; Kuhlmann K; van Berkel AM; van Leerdam ME; Virchows Arch; 2021 Sep; 479(3):451-457. PubMed ID: 33718978 [TBL] [Abstract][Full Text] [Related]
13. The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome. Kang YJ; Killen J; Caruana M; Simms K; Taylor N; Frayling IM; Snowsill T; Huxley N; Coupe VM; Hughes S; Freeman V; Boussioutas A; Trainer AH; Ward RL; Mitchell G; Macrae FA; Canfell K Med J Aust; 2020 Feb; 212(2):72-81. PubMed ID: 31595523 [TBL] [Abstract][Full Text] [Related]
14. Rates and outcomes of testing for lynch syndrome in a national colorectal cancer screening programme. Cudmore J; Kumar L; O'MorĂ¡in N; Cullen G; Horgan G; Aird J; Sheahan K; Winter DC; Kennelly R; Leyden J Cancer Epidemiol; 2023 Feb; 82():102314. PubMed ID: 36608496 [TBL] [Abstract][Full Text] [Related]
15. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome. Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinicopathological characteristics of mismatch repair-deficient colorectal carcinoma in early onset cases as compared with late-onset cases: a retrospective cross-sectional study in Northeastern Iran. Goshayeshi L; Ghaffarzadegan K; Khooei A; Esmaeilzadeh A; Rahmani Khorram M; Mosannen Mozaffari H; Kiani B; Hoseini B BMJ Open; 2018 Aug; 8(8):e023102. PubMed ID: 30166308 [TBL] [Abstract][Full Text] [Related]
17. Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience. Erten MZ; Fernandez LP; Ng HK; McKinnon WC; Heald B; Koliba CJ; Greenblatt MS Dig Dis Sci; 2016 Oct; 61(10):2887-2895. PubMed ID: 27384051 [TBL] [Abstract][Full Text] [Related]
18. Streamlining the diagnostic pathway for Lynch syndrome in colorectal cancer patients: a 10-year experience in a single Italian Cancer Center. Puccini A; Nardin S; Trevisan L; Lastraioli S; Gismondi V; Ricciotti I; Damiani A; Bregni G; Murialdo R; Pastorino A; Martelli V; Gandini A; Mastracci L; Varesco L; Dono M; Battistuzzi L; Grillo F; Sciallero S Eur J Cancer Prev; 2024 Jul; 33(4):355-362. PubMed ID: 38190337 [TBL] [Abstract][Full Text] [Related]
19. Adherence to national Lynch syndrome testing guidelines for colorectal cancer in an Aotearoa New Zealand hospital-based population. Joseph N; McGuinness M; Prosser CH; Trifinovich G; Xu W; Harmston C N Z Med J; 2024 Aug; 137(1600):31-39. PubMed ID: 39088807 [TBL] [Abstract][Full Text] [Related]
20. Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study. Lincoln A; Benton S; Piggott C; North BV; Rigney J; Young C; Quirke P; Sasieni P; Monahan KJ BMC Cancer; 2022 Nov; 22(1):1144. PubMed ID: 36344941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]